Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $7.1000 (2.01%) ($7.1000 - $7.1000) on Thu. Feb. 25, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.04% (three month average) | RSI | 71 | Latest Price | $7.1000(2.01%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -0.6% a day on average for past five trading days. | Weekly Trend | ANPC advances 7.6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) IGOV(21%) BLOK(20%) SLV(18%) GLD(17%) ICLN(16%) | Factors Impacting ANPC price | ANPC will decline at least -4.02% in a week (0% probabilities). UUP(-11%) XHB(-8%) TBT(-7%) XLP(-6%) XLF(-5%) | | | | | Relative Volatility | | | | Market Trend Strength | -4.02% (StdDev 8.04%) | Hourly BBV | -0.9 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $6.96(2.01%) | 10 Day Moving Average | $6.82(4.11%) | 20 Day Moving Average | $6.32(12.34%) | To recent high | -8.3% | To recent low | 41.7% | Market Cap | $61m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |